BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Allergy to pollen
,
Heart
,
Laryngoscope
,
BRAF
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
2 pam
Summary
General Info
Curated Studies
Most Correlated Studies
Dendritic cell stimulationed with 5 ligands over 9 time points
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Leukemia THP-1 derived macrophages treated with FSL-1, liposaccharide and Pam3CSK4
The anti-inflammatory nature of HDL in macrophages
Explore Curated Studies Results
Literature
Most Relevant Literature
Interference by pralidoxime (PAM) salts in clinical laboratory tests.
Preparing for chemical terrorism: a study of the stability of expired pralidoxime (2-PAM).
Pralidoxime inhibits paraoxon-induced depression of rocuronium-neuromuscular block in a time-depende…
Montmorillonite functionalized with pralidoxime as a material for chemical protection against organo…
Pralidoxime in organophosphorus poisoning.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Position and Angle Marking System (PAMS) for Ultrasound-guided Neuraxial Procedures
Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors
A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Acti…
Partners at Meals - Respite Care and Home (PAM)
Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ